[Antibody titers to glycolipid chemotype Re and endotoxin binding by leukocytes in suppurative meningitis]. 1996

N D Iushchuk, and V G Likhoded, and M Iu Iakovlev, and A E Kudriavtsev, and A V Apollonin, and N N Kozlova

The state of immunity to endotoxin of gram-negative bacteria in 45 patients with purulent meningitis caused by meningococci and Escherichia was studied. For comparison, similar characteristics in 35 practically healthy persons were studied. The state of immunity was evaluated by antibody titers in the passive hemagglutination inhibition test with chemotype Re glycolipid and by the content of polymorphonuclear leukocytes, capable of binding endotoxin in the blood of the examinee (in vivo determination), and leukocytes, capable of binding endotoxin during the treatment of thin blood smears (in vitro determination). Leukocytes bound with endotoxin were detected in blood smears in the enzyme immunoassay with the use of the conjugate of horse-radish peroxidase with antibodies to chemotype Re glycolipid. The study revealed that the acute period of bacterial meningitis was characterized by considerable suppression of antiendotoxin immunity. Leukocytes, binding endotoxin in vivo, as well as leukocytes, capable of binding endotoxin in vitro, were practically absent in the patients at the time of their admittance to the hospital. After treatment the characteristics of antiendotoxin immunity restored practically to normal values.

UI MeSH Term Description Entries
D008297 Male Males
D008585 Meningitis, Meningococcal A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) Meningitis, Neisseria,Neisseria Meningitis,Meningitis, Meningococcal, Serogroup A,Meningitis, Meningococcal, Serogroup B,Meningitis, Meningococcal, Serogroup C,Meningitis, Meningococcal, Serogroup W-135,Meningitis, Meningococcal, Serogroup W135,Meningitis, Meningococcal, Serogroup Y,Meningitis, Meningococcic,Meningococcal Meningitis, Serogroup A,Meningococcal Meningitis, Serogroup B,Meningococcal Meningitis, Serogroup C,Meningococcal Meningitis, Serogroup W-135,Meningococcal Meningitis, Serogroup W135,Meningococcal Meningitis, Serogroup Y,Serogroup A Meningococcal Meningitis,Serogroup B Meningococcal Meningitis,Serogroup C Meningococcal Meningitis,Serogroup W-135, Meningococcal Meningitis,Serogroup W135, Meningococcal Meningitis,Serogroup Y, Meningococcal Meningitis,Meningococcal Meningitis,Meningococcal Meningitis, Serogroup W 135,Neisseria Meningitides,Serogroup W 135, Meningococcal Meningitis
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009345 Neisseria meningitidis A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype. Diplokokkus intracellularis meningitidis,Meningococcus,Micrococcus intracellularis,Micrococcus meningitidis,Micrococcus meningitidis cerebrospinalis,Neisseria weichselbaumii
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005260 Female Females
D006017 Glycolipids Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage) Glycolipid

Related Publications

N D Iushchuk, and V G Likhoded, and M Iu Iakovlev, and A E Kudriavtsev, and A V Apollonin, and N N Kozlova
April 1990, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
N D Iushchuk, and V G Likhoded, and M Iu Iakovlev, and A E Kudriavtsev, and A V Apollonin, and N N Kozlova
April 1978, The Journal of experimental medicine,
N D Iushchuk, and V G Likhoded, and M Iu Iakovlev, and A E Kudriavtsev, and A V Apollonin, and N N Kozlova
September 1985, Lancet (London, England),
N D Iushchuk, and V G Likhoded, and M Iu Iakovlev, and A E Kudriavtsev, and A V Apollonin, and N N Kozlova
January 1992, Acta paediatrica (Oslo, Norway : 1992),
N D Iushchuk, and V G Likhoded, and M Iu Iakovlev, and A E Kudriavtsev, and A V Apollonin, and N N Kozlova
January 1994, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
N D Iushchuk, and V G Likhoded, and M Iu Iakovlev, and A E Kudriavtsev, and A V Apollonin, and N N Kozlova
July 1985, Lancet (London, England),
N D Iushchuk, and V G Likhoded, and M Iu Iakovlev, and A E Kudriavtsev, and A V Apollonin, and N N Kozlova
March 1977, Die Naturwissenschaften,
N D Iushchuk, and V G Likhoded, and M Iu Iakovlev, and A E Kudriavtsev, and A V Apollonin, and N N Kozlova
November 1975, Infection and immunity,
N D Iushchuk, and V G Likhoded, and M Iu Iakovlev, and A E Kudriavtsev, and A V Apollonin, and N N Kozlova
January 1957, Arkhiv patologii,
N D Iushchuk, and V G Likhoded, and M Iu Iakovlev, and A E Kudriavtsev, and A V Apollonin, and N N Kozlova
January 1995, Arkhiv patologii,
Copied contents to your clipboard!